These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8344349)

  • 1. Regulation of perforin gene expression in a T cell hybrid with inducible cytolytic activity.
    García-Sanz JA; Podack ER
    Eur J Immunol; 1993 Aug; 23(8):1877-83. PubMed ID: 8344349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of perforin and serine esterases in a murine cytotoxic T lymphocyte clone.
    Liu CC; Joag SV; Kwon BS; Young JD
    J Immunol; 1990 Feb; 144(4):1196-201. PubMed ID: 2406339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-4 regulation of perforin gene expression and BLT-esterase production in alpha CD3-induced activated killer cells.
    Ting CC; Liang SM; Wang J; Chen YY; Hargrove M; Xu N
    Biotechnol Ther; 1994-1995; 5(3-4):99-115. PubMed ID: 8608327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
    Makrigiannis AP; Hoskin DW
    J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perforin expression in human peripheral blood mononuclear cells. Definition of an IL-2-independent pathway of perforin induction in CD8+ T cells.
    Lu P; Garcia-Sanz JA; Lichtenheld MG; Podack ER
    J Immunol; 1992 Jun; 148(11):3354-60. PubMed ID: 1588036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction by concanavalin A of specific mRNAs and cytolytic function in a CD8-positive T cell hybridoma.
    Gu JJ; Harriss JV; Ozato K; Gottlieb PD
    J Immunol; 1994 Nov; 153(10):4408-17. PubMed ID: 7963518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-15 induces the expression of mRNAs of cytolytic mediators and augments cytotoxic activities in primary murine lymphocytes.
    Ye W; Young JD; Liu CC
    Cell Immunol; 1996 Nov; 174(1):54-62. PubMed ID: 8929454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term cytolytic mediators' expression in decidual lymphocytes is enhanced by interleukin-15.
    Strbo N; Laskarin G; Bogovic Crncic T; Juretic Frankovic K; Bedenicki I; Sotosek Tokmadzic V; Randic L; Le Bouteiller P; Tabiasco J; Podack ER; Rukavina D
    Am J Reprod Immunol; 2006 Mar; 55(3):217-25. PubMed ID: 16451356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta.
    Smyth MJ; Strobl SL; Young HA; Ortaldo JR; Ochoa AC
    J Immunol; 1991 May; 146(10):3289-97. PubMed ID: 1827481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells.
    DeBlaker-Hohe DF; Yamauchi A; Yu CR; Horvath-Arcidiacono JA; Bloom ET
    Cell Immunol; 1995 Oct; 165(1):33-43. PubMed ID: 7671323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.
    Cesano A; Visonneau S; Clark SC; Santoli D
    J Immunol; 1993 Sep; 151(6):2943-57. PubMed ID: 8104216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells.
    Smyth MJ; Ortaldo JR; Bere W; Yagita H; Okumura K; Young HA
    J Immunol; 1990 Aug; 145(4):1159-66. PubMed ID: 2143209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of perforin and granzyme messenger RNA expression in human natural killer cells.
    Salcedo TW; Azzoni L; Wolf SF; Perussia B
    J Immunol; 1993 Sep; 151(5):2511-20. PubMed ID: 8103068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of natural killer cell activity and perforin and granzyme B gene expression following continuous culture of short pulse with interleukin-12 in young and old mice.
    Argentati K; Bartozzi B; Bernardini G; Di Stasio G; Provinciali M
    Eur Cytokine Netw; 2000 Mar; 11(1):59-66. PubMed ID: 10705300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y; Thoburn CJ; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic control of perforin gene expression. Functional evidence for two separate control regions.
    Lichtenheld MG; Podack ER; Levy RB
    J Immunol; 1995 Mar; 154(5):2153-63. PubMed ID: 7868890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines.
    Sun R; Li AL; Wei HM; Tian ZG
    Cell Res; 2004 Feb; 14(1):67-73. PubMed ID: 15040892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome.
    Rafi AQ; Zeytun A; Bradley MJ; Sponenberg DP; Grayson RL; Nagarkatti M; Nagarkatti PS
    J Immunol; 1998 Sep; 161(6):3077-86. PubMed ID: 9743374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.